Paper Details

  1. Home
  2. Paper Details

Optimizing bexarotene therapy for cutaneous T-cell lymphoma.

Author: ApisarnthanaraxNarin, Breuer-MchamJoan, DuvicMadeleine, TalpurRakhshandra, WardStaci

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Bexarotene, a retinoid used for cutaneous T-cell lymphoma, has a response rate of 45% at the optimal dose. Hypertriglyceridemia is a common side effect, often requiring the use of lipid-lowering agents such as statins.
Paper Details　
Original Abstract of the Article :
Bexarotene (Targretin oral capsules), the first RXR-selective retinoid "rexinoid" approved for all stages of cutaneous T-cell lymphoma (CTCL), had a response rate (RR) of 45% at the optimal dose of 300 mg/m(2) per day in 2 multicenter trials. With hypertriglyceridemia reported at 79%, bexarotene is ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1067/mjd.2002.124607

データ提供：米国国立医学図書館（NLM）

Optimizing Bexarotene Therapy for Cutaneous T-Cell Lymphoma (CTCL)

This research investigates the use of [drug name] in treating [disease name], a type of skin cancer. The authors examine the efficacy and safety of this drug, highlighting the importance of [optimal dosing] and potential side effects such as [specific side effect]. They also discuss the potential interaction between [drug name] and other medications, specifically [statins].

Bexarotene: Optimizing Treatment for Cutaneous T-Cell Lymphoma

The research suggests that [drug name] can be an effective treatment for [disease name] when used at the optimal dose. However, it also underscores the importance of careful monitoring for potential side effects and potential interactions with other medications.

Navigating the Challenges of Cancer Treatment: A Focus on Personalized Medicine

This study highlights the importance of personalized medicine in cancer treatment. By carefully considering individual factors such as [specific factors], healthcare providers can optimize treatment outcomes and minimize potential side effects.

Dr.Camel's Conclusion

This research is like a camel navigating a treacherous desert landscape, seeking the best path to treat [disease name]. It emphasizes the importance of finding the right balance between efficacy and safety in cancer treatment, ensuring optimal outcomes for those facing this challenging condition.

Date :
  1. Date Completed 2002-11-15
  2. Date Revised 2019-07-09
Further Info :

Pubmed ID

12399758

DOI: Digital Object Identifier

10.1067/mjd.2002.124607

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.